Genetics

This blog post examines a recent study evaluating the performance of a multiple sclerosis polygenic risk score across European, African, and Latino/admixed American ancestry groups using data from the All of Us Research Program. The article highlights that while the score effectively stratified multiple sclerosis risk among European and Latino/admixed American participants, it did not perform significantly in individuals of African ancestry. These findings underscore a central challenge in precision medicine: genetic prediction tools developed primarily from European-ancestry data may not generalize equitably across diverse populations. The discussion emphasizes the need for ancestry-inclusive genome-wide association studies, population-specific risk models, and more representative genomic datasets to ensure that advances in genetic medicine benefit all communities.